Compounds > efegatran
Page last updated: 2024-09-03

efegatran and n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide

efegatran has been researched along with n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide in 1 studies

Compound Research Comparison

Studies
(efegatran)		Trials
(efegatran)		Recent Studies (post-2010)
(efegatran)		Studies
(n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide)		Trials
(n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide)		Recent Studies (post-2010) (n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide)
43305202

Protein Interaction Comparison

ProteinTaxonomyefegatran (IC50)n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide (IC50)
ProthrombinHomo sapiens (human)0.69
Trypsin-1Homo sapiens (human)0.169
Trypsin-2Homo sapiens (human)0.169
Trypsin-3Homo sapiens (human)0.169

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naylor-Olsen, AM; Sanderson, PE1

Reviews

1 review(s) available for efegatran and n(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide

ArticleYear
Thrombin inhibitor design.
    Current medicinal chemistry, 1998, Volume: 5, Issue:4

    Topics: Anticoagulants; Antithrombins; Arginine; Binding Sites; Dipeptides; Drug Design; Humans; Models, Molecular; Oligopeptides; Pipecolic Acids; Piperidines; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Sulfonamides; Thrombin

1998